Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

Similar articles for PubMed (Select 18719787)

1.

Neuroendocrine tumors: a registry of 1,000 patients.

Younes RN; GETNE (Grupo de Estudo de Tumores Neuroendócrinos).

Rev Assoc Med Bras. 2008 Jul-Aug;54(4):305-7.

2.

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.

Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G.

Endocr Relat Cancer. 2005 Dec;12(4):1083-92.

3.

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.

Strosberg J, Nasir A, Coppola D, Wick M, Kvols L.

Hum Pathol. 2009 Sep;40(9):1262-8. doi: 10.1016/j.humpath.2009.01.010. Epub 2009 Apr 14.

PMID:
19368957
4.

Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center.

Pape UF, Böhmig M, Berndt U, Tiling N, Wiedenmann B, Plöckinger U.

Ann N Y Acad Sci. 2004 Apr;1014:222-33.

PMID:
15153439
5.

Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.

Yildiz O, Ozguroglu M, Yanmaz T, Turna H, Serdengecti S, Dogusoy G.

Med Oncol. 2010 Dec;27(4):1050-6. doi: 10.1007/s12032-009-9332-7. Epub 2009 Nov 3.

PMID:
19908171
6.

Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.

Rothenstein J, Cleary SP, Pond GR, Dale D, Gallinger S, Moore MJ, Brierley J, Siu LL.

Am J Clin Oncol. 2008 Feb;31(1):64-70. doi: 10.1097/COC.0b013e31807a2f49.

PMID:
18376230
7.

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

Pape UF, Berndt U, Müller-Nordhorn J, Böhmig M, Roll S, Koch M, Willich SN, Wiedenmann B.

Endocr Relat Cancer. 2008 Dec;15(4):1083-97. doi: 10.1677/ERC-08-0017. Epub 2008 Jul 4.

8.

Neuroendocrine tumours: clinical presentation and management of localized disease.

Kulke MH.

Cancer Treat Rev. 2003 Oct;29(5):363-70. Review.

PMID:
12972355
9.

The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors.

Ploeckinger U, Kloeppel G, Wiedenmann B, Lohmann R; representatives of 21 German NET Centers.

Neuroendocrinology. 2009;90(4):349-63. doi: 10.1159/000242109. Epub 2009 Sep 23.

10.

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.

van Vilsteren FG, Baskin-Bey ES, Nagorney DM, Sanderson SO, Kremers WK, Rosen CB, Gores GJ, Hobday TJ.

Liver Transpl. 2006 Mar;12(3):448-56.

11.

[Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].

Brüwer M, Pahlov-Nejad T, Herbst H, Senninger N, Schürmann G.

Zentralbl Chir. 2003 Aug;128(8):656-62. German.

PMID:
12931261
12.

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A.

J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14.

PMID:
19365596
13.

Surgical treatment of gastrointestinal neuroendocrine tumors.

Fendrich V, Bartsch DK.

Langenbecks Arch Surg. 2011 Mar;396(3):299-311. doi: 10.1007/s00423-011-0741-7. Epub 2011 Feb 1. Review.

PMID:
21279821
14.

[Endoscopic ultrasonography in patients suspected of neuroendocrine tumours].

Ainsworth AP, Fristrup CW, Mortensen MB, Nielsen HO.

Ugeskr Laeger. 2008 May 26;170(22):1938-40. Danish.

PMID:
18513479
15.

[Contemporary methods of diagnosis and treatment of neuroendocrine gastrointestinal tumors].

Kos-Kudła B, Zemczak A.

Endokrynol Pol. 2006 Mar-Apr;57(2):174-86. Review. Polish.

PMID:
16773594
16.

Resectability of primary gastroenteropancreatic neuroendocrine tumor as a prognostic factor for survival.

Medrano-Guzmán R, López-García SC, Torres-Vargas S, González-Rodríguez D, Alvarado-Cabrero I.

Cir Cir. 2011 Nov-Dec;79(6):498-504. English, Spanish.

PMID:
22169366
17.

[Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors].

Han JH, Kim MH, Moon SH, Park SJ, Park do H, Lee SS, Seo DW, Lee SK, Kim SC, Han DJ.

Korean J Gastroenterol. 2009 Feb;53(2):98-105. Korean.

18.

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.

Pape UF, Jann H, Müller-Nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B.

Cancer. 2008 Jul 15;113(2):256-65. doi: 10.1002/cncr.23549.

19.
20.

Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Oberg K, Jelic S; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii104-5. doi: 10.1093/annonc/mdn117. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk